Haegarda and Ustekinumab Intravenous Infusion
Determining the interaction of Haegarda and Ustekinumab Intravenous Infusion and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Haegarda, Berinert, Cinryze, Ruconest
Synonyms: n.a.
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Haegarda-Ustekinumab Subcutaneous
- Haegarda-Ustekinumab Subcutaneous Injection
- Haegarda-Ustell
- Haegarda-UTA
- Haegarda-UTA Capsules
- Haegarda-UTAC tablets
- Ustekinumab Intravenous Infusion-Haemonetics Anticoagulant Sodium Citrate
- Ustekinumab Intravenous Infusion-Haemophilus b conjugate (PRP-OMP) vaccine
- Ustekinumab Intravenous Infusion-Haemophilus b conjugate (PRP-T) vaccine
- Ustekinumab Intravenous Infusion-Haemophilus b conjugate and hepatitis b vaccine Intramuscular
- Ustekinumab Intravenous Infusion-Haemophilus b Conjugate Vaccine
- Ustekinumab Intravenous Infusion-Haemophilus b conjugate vaccine Intramuscular